Mersana Therapeutics Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Marty Huber
Chief executive officer
US$3.0m
Total compensation
| CEO salary percentage | 6.4% |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 3.3yrs |
| Board average tenure | 7.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$3m | US$194k | -US$172m |
| Sep 30 2023 | n/a | n/a | -US$197m |
| Jun 30 2023 | n/a | n/a | -US$215m |
| Mar 31 2023 | n/a | n/a | -US$213m |
| Dec 31 2022 | US$163k | n/a | -US$204m |
| Sep 30 2022 | n/a | n/a | -US$208m |
| Jun 30 2022 | n/a | n/a | -US$194m |
| Mar 31 2022 | n/a | n/a | -US$183m |
| Dec 31 2021 | US$290k | n/a | -US$170m |
| Sep 30 2021 | n/a | n/a | -US$150m |
| Jun 30 2021 | n/a | n/a | -US$127m |
| Mar 31 2021 | n/a | n/a | -US$106m |
| Dec 31 2020 | US$303k | n/a | -US$88m |
Compensation vs Market: Marty's total compensation ($USD3.04M) is above average for companies of similar size in the German market ($USD1.02M).
Compensation vs Earnings: Marty's compensation has increased whilst the company is unprofitable.
CEO
Marty Huber (62 yo)
less than a year
Tenure
US$3,044,085
Compensation
Dr. Martin H. Huber, also known as Marty, M.D., is President and Chief Executive Officer at Mersana Therapeutics, Inc. since September 2023. He served as President and Head of R&D at Xilio Therapeutics, In...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$3.04m | no data | |
| Senior VP | 4.8yrs | US$1.74m | 0.045% $ 150.8k | |
| Senior VP and Chief Science & Technology Officer | 16.2yrs | US$1.69m | 0.16% $ 551.3k | |
| Senior VP | 3yrs | US$1.61m | 0.023% $ 75.8k | |
| Senior VP & Chief Development Officer | 2.5yrs | US$1.58m | 0.012% $ 38.9k | |
| Co-Founder | no data | no data | no data | |
| Chief Accounting Officer | 4.6yrs | no data | 0.021% $ 71.8k | |
| Senior Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Senior Vice President of Regulatory Affairs | 3.7yrs | no data | no data | |
| Exe. Director and Head of Biology | no data | no data | no data | |
| Senior VP & Chief Manufacturing Officer | 2.7yrs | US$1.68m | 0.015% $ 49.7k |
3.3yrs
Average Tenure
58yo
Average Age
Experienced Management: 0M4's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4yrs | US$3.04m | no data | |
| Independent Chairman | 11.8yrs | US$329.93k | 0.48% $ 1.6m | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 6.6yrs | US$308.93k | 0.0018% $ 5.9k | |
| Independent Director | 6.1yrs | US$305.43k | 0.020% $ 68.3k | |
| Independent Director | 7.7yrs | US$293.43k | 0% $ 0 | |
| Director | 9.1yrs | US$4.65m | 0.35% $ 1.2m | |
| Independent Director | 7.3yrs | US$297.43k | 0% $ 0 | |
| Board Observer | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
7.3yrs
Average Tenure
59.5yo
Average Age
Experienced Board: 0M4's board of directors are considered experienced (7.3 years average tenure).